Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Julphar
Cipla
Chinese Patent Office
UBS
McKinsey
Covington
Harvard Business School
Merck
QuintilesIMS

Generated: August 19, 2017

DrugPatentWatch Database Preview

Pernix Ireland Pain Company Profile

« Back to Dashboard

What is the competitive landscape for PERNIX IRELAND PAIN, and when can generic versions of PERNIX IRELAND PAIN drugs launch?

PERNIX IRELAND PAIN has one approved drug.

There are twelve US patents protecting PERNIX IRELAND PAIN drugs.

There are one hundred and forty-seven patent family members on PERNIX IRELAND PAIN drugs in thirty-three countries.

Summary for Applicant: Pernix Ireland Pain

Patents:12
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pernix Ireland Pain
ZOHYDRO ER
hydrocodone bitartrate
CAPSULE, EXTENDED RELEASE;ORAL202880-004Oct 25, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Pernix Ireland Pain
ZOHYDRO ER
hydrocodone bitartrate
CAPSULE, EXTENDED RELEASE;ORAL202880-006Oct 25, 2013RXYesNo► Subscribe► Subscribe ► Subscribe
Pernix Ireland Pain
ZOHYDRO ER
hydrocodone bitartrate
CAPSULE, EXTENDED RELEASE;ORAL202880-006Oct 25, 2013RXYesNo► Subscribe► Subscribe ► Subscribe
Pernix Ireland Pain
ZOHYDRO ER
hydrocodone bitartrate
CAPSULE, EXTENDED RELEASE;ORAL202880-005Oct 25, 2013RXYesNo► Subscribe► SubscribeY ► Subscribe
Pernix Ireland Pain
ZOHYDRO ER
hydrocodone bitartrate
CAPSULE, EXTENDED RELEASE;ORAL202880-004Oct 25, 2013RXYesNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for PERNIX IRELAND PAIN drugs

Drugname Dosage Strength Tradename Submissiondate
hydrocodone bitartrate
Extended-release Capsules10 mg, 15 mg, 20 mg, 30 mg, 40 mg, and 50 mg
ZOHYDRO ER
2/26/2014

Non-Orange Book Patents for Pernix Ireland Pain

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,730,325 Multiparticulate modified release composition► Subscribe
7,580,712Wireless high-speed data network planning tool► Subscribe
9,421,201Treating pain in patients with hepatic impairment► Subscribe
6,793,936 Multiparticulate modified release composition► Subscribe
8,119,163Nanoparticulate and controlled release compositions comprising cefditoren► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Pernix Ireland Pain Drugs

Country Document Number Estimated Expiration
MexicoPA01004381► Subscribe
Norway20090158► Subscribe
World Intellectual Property Organization (WIPO)2008073068► Subscribe
Mexico2008016115► Subscribe
China1403076► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Queensland Health
Boehringer Ingelheim
Express Scripts
Dow
Fish and Richardson
Deloitte
Johnson and Johnson
US Army
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot